Fujifilm India Installs 125 AMULET Innovality Digital Mammography Machines Across India

New Delhi : FUJIFILM India, a leading pioneer in advancing healthcare imaging technologies, has achieved a significant milestone by deploying 125 AMULET Innovality digital mammography machines across India, marking a noteworthy advancement in the field of digital mammography. This achievement underscores the company’s commitment to enhancing the fight against breast cancer and expanding its installation base continually.

According to Globocan data from 2020, breast cancer constituted 13.5% (178,361 cases) of all cancer diagnoses and 10.6% (90,408 cases) of all cancer-related deaths in India. These statistics emphasize the critical importance of early breast cancer detection in improving survival rates.

As reported by IndiaEducationDiary.com, FUJIFILM India believes it has a societal obligation to raise awareness about early breast cancer detection and equip healthcare professionals with cutting-edge technologies to better serve the community. To further this mission, the ‘Together Against Breast Cancer’ conference was held in Goa from September 15th to 17th, 2023.

Koji Wada, Managing Director, FUJIFILM India said, “At FUJIFILM India, our unwavering commitment to women’s health is exemplified by the technologies we bring and the advocacy we do for early diagnosis. The installation of 125 AMULET Innovality digital mammography machines across India are a testament to our dedication to enhance healthcare infrastructure for the early detection of breast cancer. However, I strongly feel that 125 is just a milestone in this journey and we will be expanding our installation base with a very fast pace in the near future. Beyond our advancements in healthcare technology, our ‘Together Against Breast Cancer’ Conference is proudly celebrating its 3rd edition, reinforcing our commitment to raising awareness. We firmly believe that improving access to technology and increasing awareness are pivotal steps toward fostering a healthier India”.

Related Posts

Multi-State Supply Chain of Fake RituxiRel and Alburel Injections Exposed Amid Health Risks

Pune— In a major breakthrough exposing vulnerabilities in India’s pharmaceutical supply chain, the Food and Drug Administration (FDA) Pune Division has declared batches of “RituxiRel” (a counterfeit version of Rituximab,…

TN, Karnataka, Rajasthan declare highest number of NSQs in January

New Delhi:  Around 29% of the total Not of Standard Quality (NSQ) drug samples reported by the State drug testing laboratories in the month of January were collected and tested…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Multi-State Supply Chain of Fake RituxiRel and Alburel Injections Exposed Amid Health Risks

Multi-State Supply Chain of Fake RituxiRel and Alburel Injections Exposed Amid Health Risks

TN, Karnataka, Rajasthan declare highest number of NSQs in January

TN, Karnataka, Rajasthan declare highest number of NSQs in January

Centre reorganises CDSCO Zone Baddi amid Drug Quality Concerns

Centre reorganises CDSCO Zone Baddi amid Drug Quality Concerns

CDSCO modifies norms for testing permissions to speed up drug approvals

CDSCO modifies norms for testing permissions to speed up drug approvals

British men jailed for smuggling cocaine into Bali

British men jailed for smuggling cocaine into Bali

Andhra milk adulteration: Four dead, seven in critical condition

Andhra milk adulteration: Four dead, seven in critical condition